H. Lundbeck A/S (HLBBF)
8.75
0.00 (0.00%)
USD |
OTCM |
Nov 18, 16:00
H. Lundbeck Price : 8.75 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 8.75 | 8.75 | 8.75 | 8.75 | 0.000 |
| Nov 17, 2026 | 8.75 | 8.75 | 8.75 | 8.75 | 0.000 |
| Nov 16, 2026 | 8.75 | 8.75 | 8.75 | 8.75 | 107.00 |
| Nov 13, 2026 | 9.09 | 9.09 | 9.09 | 9.09 | 0.000 |
| Nov 12, 2026 | 9.09 | 9.09 | 9.09 | 9.09 | 100.00 |
| Nov 11, 2026 | 7.10 | 7.10 | 7.10 | 7.10 | 0.000 |
| Nov 10, 2026 | 7.10 | 7.10 | 7.10 | 7.10 | 0.000 |
| Nov 09, 2026 | 7.10 | 7.10 | 7.10 | 7.10 | 0.000 |
| Nov 06, 2026 | 7.10 | 7.10 | 7.10 | 7.10 | 0.000 |
| Nov 05, 2026 | 7.10 | 7.10 | 7.10 | 7.10 | 0.000 |
| Nov 04, 2026 | 7.10 | 7.10 | 7.10 | 7.10 | 0.000 |
| Nov 03, 2026 | 7.10 | 7.10 | 7.10 | 7.10 | 0.000 |
| Nov 02, 2026 | 7.10 | 7.10 | 7.10 | 7.10 | 0.000 |
| Oct 30, 2026 | 7.10 | 7.10 | 7.10 | 7.10 | 0.000 |
| Oct 29, 2026 | 7.10 | 7.10 | 7.10 | 7.10 | 0.000 |
| Oct 28, 2026 | 7.10 | 7.10 | 7.10 | 7.10 | 0.000 |
| Oct 27, 2026 | 7.10 | 7.10 | 7.10 | 7.10 | 0.000 |
| Oct 26, 2026 | 7.10 | 7.10 | 7.10 | 7.10 | 0.000 |
| Oct 23, 2026 | 7.10 | 7.10 | 7.10 | 7.10 | 301.00 |
| Oct 22, 2026 | 7.10 | 7.10 | 7.10 | 7.10 | 0.000 |
| Oct 21, 2026 | 7.10 | 7.10 | 7.10 | 7.10 | 0.000 |
| Oct 20, 2026 | 7.10 | 7.10 | 7.10 | 7.10 | 0.000 |
| Oct 19, 2026 | 7.10 | 7.10 | 7.10 | 7.10 | 100.00 |
| Oct 16, 2026 | 7.10 | 7.10 | 7.10 | 7.10 | 0.000 |
| Oct 15, 2026 | 7.10 | 7.10 | 7.10 | 7.10 | 700.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novo Nordisk A/S | 39.43 |
| ALK-Abello A/S | 36.50 |
| Xeris Biopharma Holdings, Inc. | 16.99 |
| AstraZeneca PLC | 178.76 |
| ANI Pharmaceuticals, Inc. | 71.47 |
Price Related Metrics
| PE Ratio | 13.80 |
| PS Ratio | 2.134 |
| PEG Ratio | 1.033 |
| Price to Book Value | 2.022 |
| Price to Free Cash Flow | 12.07 |
| Earnings Yield | 7.24% |
| Market Cap | 8.681B |
| PEGY Ratio | 0.8933 |
| Operating PE Ratio | 8.367 |
| Normalized PE Ratio | 12.90 |